Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_GrowTogether_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1837441699746140160.png) Learn & Grow Together [@_GrowTogether_](/creator/twitter/_GrowTogether_) on x XXX followers
Created: 2025-07-23 13:46:25 UTC

#DrReddys Q1 Results 💊📊

✅ Net Profit at ₹14.18B vs ₹13.9B YoY (Est: ₹14.78B)
✅ Revenue rises to ₹85.72B vs ₹76.96B YoY (Est: ₹86.76B)
✅ EBITDA at ₹21.73B vs ₹21.3B YoY (Est: ₹22.02B)
✅ EBITDA Margin at XXXXX% vs XXXXX% YoY (Est: 25.4%)

#Q1FY25 #Earnings #Pharma #StockMarket


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948016856159354922/c:line.svg)

**Related Topics**
[stockmarket](/topic/stockmarket)

[Post Link](https://x.com/_GrowTogether_/status/1948016856159354922)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

GrowTogether Avatar Learn & Grow Together @GrowTogether on x XXX followers Created: 2025-07-23 13:46:25 UTC

#DrReddys Q1 Results 💊📊

✅ Net Profit at ₹14.18B vs ₹13.9B YoY (Est: ₹14.78B) ✅ Revenue rises to ₹85.72B vs ₹76.96B YoY (Est: ₹86.76B) ✅ EBITDA at ₹21.73B vs ₹21.3B YoY (Est: ₹22.02B) ✅ EBITDA Margin at XXXXX% vs XXXXX% YoY (Est: 25.4%)

#Q1FY25 #Earnings #Pharma #StockMarket

XX engagements

Engagements Line Chart

Related Topics stockmarket

Post Link

post/tweet::1948016856159354922
/post/tweet::1948016856159354922